« Back
Home /
Batefenterol

Batefenterol

Manufacturer	MedChem Express
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Skin Cancer
Type	Inhibitors
Specific against	other
Amount	50 mg
Quantity options	100 mg 10mM/1mL 10 mg 1 mg 50 mg 5 mg
Item no.	HY-12980-50mg
Targets	Adrenergic Receptor; mAChR
CASRN	743461-65-6
eClass 6.1	30220300
eClass 9.0	32160605
Available
Alias	GSK961081; TD-5959
Purity	98.30
Product Description	Batefenterol (GSK961081; TD-5959) is a novel muscarinic receptor antagonist and β2-adrenoceptor agonist; displays high affinity for hM2, hM3 muscarinic and hβ2-adrenoceptor with Ki values of 1.4, 1.3 and 3.7 nM, respectively.
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	COVID-19-immunoregulation
MolecularWeight	740.24
Clinical_Information	Phase 2
Manufacturers Research Area	Inflammation/Immunology; Endocrinology
Solubility	DMSO : ≥ 100 mg/mL
Manufacturers Target	Adrenergic Receptor; mAChR
Isoform	mAChR2; mAChR3
Pathway	GPCR/G Protein; Neuronal Signaling

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-12980-50mg-safety-datasheet.pdf